language-icon Old Web
English
Sign In
Acemap > Paper > 3-Fold increase in survival for stage IV melanoma patients treated with MCV allogeneic vaccine: confirmation of previous phase II data

3-Fold increase in survival for stage IV melanoma patients treated with MCV allogeneic vaccine: confirmation of previous phase II data

1999 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.